Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus
Mina Yabusaki(Sysmex (Japan)), Tetsuya Nakatsura(Unknown), Keigo Gohda(Kansai University), Yu Sawada(Shizuoka Cancer Center), Toshiaki Yoshikawa(Aichi Cancer Center), Daisuke Nobuoka(Fukuyama City Hospital), Masaaki Ito(National Cancer Centre Japan), Takatsugu Okegawa(Kyorin University), Atsushi Kohyama(National Cancer Center Hospital East), Kiyoshi Takamatsu(Tokyo Dental College Ichikawa General Hospital), Takashi Kojima(National Cancer Center Hospital East), Masaru Nakamura(Tokyo Dental College Ichikawa General Hospital), Jun Sato(National Cancer Centre Japan), Katsuhiro Murakami(Sysmex (Japan)), Kazuhiro Kaneko(National Cancer Center Hospital East)
Cited by 18
Related Papers
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
|JAMA Oncology|2018|518
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304